Apnimed Inc. (APMD)
NasdaqGS: APMD
· リアルタイム株価 · USD
27.37
+1.74 (6.79%)
終値時点: Aug 25, 2026, 3:59 PM
株価、主要な数字、最新ニュースをひとまとめにしたページです。
Apnimed Inc.(APMD)の株価・分析・データ
6.79% (1D)
APMDについて
Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets. It offers AD109, an oral therapy designed to treat obstructive sleep apnea (OSA) by targeting the underlying neuromuscular dysfunction. The company was incorporated in 2017 and is headquartered in Cambridge, Massachusetts....
企業情報の全文


